Prognostic Implications of the Immunohistochemical Expression of Human Kallikreins 5, 6, 10 and 11 in Renal Cell Carcinoma (original) (raw)

Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers

Richard B Arenas MD

Breast Diseases: A Year Book Quarterly, 2012

View PDFchevron_right

Expression of 6 Common Antigenic Markers in Invasive Ductal Breast Carcinoma

ΘΕΟΔΩΡΟΣ ΛΙΑΛΙΑΡΗΣ

Applied Immunohistochemistry & Molecular Morphology, 2011

View PDFchevron_right

Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: An independent indicator of favourable prognosis in breast cancer

R. Ponzone

British Journal of Cancer, 2002

View PDFchevron_right

Relationship between the expression of various markers and prognostic factors in breast cancer

Nadeem Akhtar

Acta Histochemica, 2005

View PDFchevron_right

Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis

R. Ponzone

British Journal of Cancer, 2002

View PDFchevron_right

Prognostic molecular markers in early breast cancer

Francisco Esteva

Breast cancer research : BCR, 2004

View PDFchevron_right

Prognostic Biomarkers in Breast Cancer: Factors Affecting Immunohistochemical Evaluation

William Grizzle

The Breast Journal, 1995

View PDFchevron_right

Protein Biomarker Expression in Invasive Breast Carcinoma , NST Classified According to Age , TNM and Original Nottingham Prognostic Index – A Study in Kosovo

Fisnik Kurshumliu

2018

View PDFchevron_right

Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma

Maroulio Talieri

Thrombosis and Haemostasis, 2003

View PDFchevron_right

Quantitative Reverse Transcription-PCR Assay for Detection of mRNA Encoding Full-Length Human Tissue Kallikrein 7: Prognostic Relevance of KLK7 mRNA Expression in Breast Cancer

Viktor Magdolen

2000

View PDFchevron_right

Molecular and biological characteristics of breast cancer

D. Shapochka

2013

View PDFchevron_right

Bioclinical markers in breast cancer: updates and perspectives

Maria Di Vita

Frontiers in Bioscience, 2010

View PDFchevron_right

Expression of human Kallikrein 14 (KLK14) in breast cancer

E. Mayordomo

2006

View PDFchevron_right

Molecular and clinicopathological markers of prognosis in breast cancer

Kyle Matchett

Expert Review of Molecular Diagnostics, 2013

View PDFchevron_right

Biomarkers in breast cancer

Svetislav Vrbic

Jugoslovenska medicinska biohemija, 2006

View PDFchevron_right

Biomolecular markers of breast cancer

Giulio F Tarro

Frontiers in Bioscience, 2006

View PDFchevron_right

Serological and immunohistochemical detection of a 65-kDa oncofetal protein in breast cancer

Marek Mirowski

European Journal of Cancer, 1994

View PDFchevron_right

Expression of Molecular Markers in Tumours of Patients with Breast Cancer

D. Shapochka

Journal of Cytology & Histology, 2013

View PDFchevron_right

Detection of K19 mRNA Compared with Tumour Markers in Peripheral Blood from Breast Cancer Patients

Dr Labiba Temmim

Medical Principles and Practice, 2001

View PDFchevron_right

Human Kallikrein Gene 5 (KLK5) Expression by Quantitative PCR: An Independent Indicator of Poor Prognosis in Breast Cancer

Andrea Biglia

2002

View PDFchevron_right

Quantitative CK19 biomarker detection in breast cancer cell lines

Mana Oloomi

Journal of Medicine and Life

View PDFchevron_right

Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas

François Martini

International Journal of Cancer, 1997

View PDFchevron_right

Molecular aspects of early stages of breast cancer progression

Ann Thor, Sheri Krams

Journal of Cellular Biochemistry, 1993

View PDFchevron_right

High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer

Benny Jensen

Clinical cancer research : an official journal of the American Association for Cancer Research, 2003

View PDFchevron_right

Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas

Jozef Skarda, Eduard Fridman, Z. Kolar, Gulisa Turashvili

Biomedical Papers, 2007

View PDFchevron_right

Marker Expression and Differentiation in Human Breast Cancer

Jorge Schiaffi

Annals of the New York Academy of Sciences, 1993

View PDFchevron_right

YKL-40 - a New Diagnostic Biomarker for Benign Breast Diseases and Breast Cancer

V. Sarafian

2010

View PDFchevron_right

Expression of unusual immunohistochemical markers in mucinous breast carcinoma

Rodrigo Natal

Acta histochemica, 2017

View PDFchevron_right

Classification of patients with breast cancer according to Nottingham Prognostic Index highlights significant differences in immunohistochemical marker expression

Mehdi Alimehmeti, Fisnik Kurshumliu

World Journal of Surgical Oncology, 2014

View PDFchevron_right

Identification of specific nuclear structural protein alterations in human breast cancer

Sebastian Franken

Journal of Cellular Biochemistry, 2011

View PDFchevron_right

RECK is not an independent prognostic marker for breast cancer

Leticia Labriola

BMC cancer, 2015

View PDFchevron_right

Quantitative Reverse Transcription-PCR Assay for Detection of mRNA Encoding Full-Length Human Tissue Kallikrein 7: Prognostic Relevance of KLK7 mRNA Expression in Breast Cancer 3

Fred C. G. J. Sweep

Clinical Chemistry, 2006

View PDFchevron_right

Assessment of Cytokeratin Expression in Carcinoma Breast

Sunita Vagha

Journal of Evolution of Medical and Dental Sciences, 2020

View PDFchevron_right